A detailed history of Eagle Bluffs Wealth Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Eagle Bluffs Wealth Management LLC holds 2,494 shares of ABBV stock, worth $508,451. This represents 0.25% of its overall portfolio holdings.

Number of Shares
2,494
Previous 2,447 1.92%
Holding current value
$508,451
Previous $445,000 4.04%
% of portfolio
0.25%
Previous 0.28%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

BUY
$154.79 - $180.76 $7,275 - $8,495
47 Added 1.92%
2,494 $427,000
Q1 2023

May 04, 2023

BUY
$144.61 - $166.54 $21,691 - $24,981
150 Added 6.53%
2,447 $389,000
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $14,628 - $16,778
-109 Reduced 4.53%
2,297 $308,000
Q1 2022

May 16, 2022

BUY
$131.98 - $163.75 $2,375 - $2,947
18 Added 0.75%
2,406 $390,000
Q4 2021

Feb 15, 2022

BUY
$107.43 - $135.93 $256,542 - $324,600
2,388 New
2,388 $323,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $360B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Eagle Bluffs Wealth Management LLC Portfolio

Follow Eagle Bluffs Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Bluffs Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Bluffs Wealth Management LLC with notifications on news.